 | • レポートコード：PMR2009039 • 出版社/出版日：Persistence Market Research / 2020年8月13日 • レポート形態：英文、PDF、300ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Individual User（1名用） | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User（5名用） | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Corporate User（企業用） | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、消化性潰瘍治療薬の世界市場を徹底調査するとともに、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、主要成功要因、価格分析・予測、価格分析、製品別（プロトンポンプ阻害剤、カリウムイオン競合型アシッドブロッカー（P-CAB）、制酸剤、H2-拮抗薬、抗生物質）分析、疾患別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD））分析、流通チャネル別（病院薬局、民間クリニック、ドラッグストア、小売薬局、Eコマース）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを明らかに致します。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・主要成功要因 ・価格分析・予測 ・価格分析 ・消化性潰瘍治療薬の世界市場規模：製品別（プロトンポンプ阻害剤、カリウムイオン競合型アシッドブロッカー（P-CAB）、制酸剤、H2-拮抗薬、抗生物質） ・消化性潰瘍治療薬の世界市場規模：疾患別（胃炎、胃潰瘍、十二指腸潰瘍、胃食道逆流症（GERD）） ・消化性潰瘍治療薬の世界市場規模：流通チャネル別（病院薬局、民間クリニック、ドラッグストア、小売薬局、Eコマース） ・消化性潰瘍治療薬の世界市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Peptic Ulcer Drugs Market – Scope of the Report
Persistence Market Research (PMR) recently published a market study on the global peptic ulcer drugs market. The study provides detailed assessment of key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the peptic ulcer drugs market structure. The market study presents exclusive information about how the peptic ulcer drugs market will grow during the forecast period (2020-2030).
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compound annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes definitions, drivers, and opportunity analysis by region and by product, which helps in the deep understanding of the market segment details by researchers, suppliers, manufactures, and distributors. This information can help readers understand the quantitative growth prospects of the peptic ulcer drugs market during the forecast period.
The study is relevant for manufacturers, physicians, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researchers, shareholders, and industry experts can leverage the information and data presented in PMR’s study.
The study also includes statistics as well as facts related to the macroeconomics factors that are impacting developments in the peptic ulcer drugs market. It also offers actionable insights based on the future trends in the peptic ulcer drugs market. Furthermore, small businesses and new entrants in the peptic ulcer drugs market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.
Questions Answered in PMR’s Peptic Ulcer Drugs Market Report
Which regions will continue to remain the most profitable regional markets for peptic ulcer drugs market players?
Which factors will induce a change in the demand for peptic ulcer drugs during the assessment period?
What are the different opportunities available for emerging players in the peptic ulcer drugs market?
How are supply-side and demand-side drivers impacting the peptic ulcer drugs market?
How will changing trends impact the peptic ulcer drugs market?
How can market players capture the low-hanging opportunities in the peptic ulcer drugs market in developed regions?
Which companies are leading the peptic ulcer drugs market?
What are the winning strategies of stakeholders in the peptic ulcer drugs market to upscale their position in this landscape?
Peptic Ulcer Drugs Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the peptic ulcer drugs market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the peptic ulcer drugs market study include statistics from government healthcare organizations, medicines journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the peptic ulcer drugs market, and makes PMR’s projections on the growth prospects of the peptic ulcer drugs market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.2. Forecast Factors – Relevance & Impact
4.3. Current COVID19 Statistics and Probable Future Impact
4.3.1. Current COVID19 Statistics and Probable Future Impact
4.3.2. Current GDP Projection and Probable Impact
4.3.3. Current Economic Projection as compared to 2008 Economic analysis
4.3.4. COVID19 and Impact Analysis
4.3.4.1. Revenue By Product
4.3.4.2. Revenue By Indication
4.3.4.3. Revenue By Distribution Channel
4.3.5. 2020 Market Scenario
4.3.6. Quarter by Quarter Forecast
4.3.7. Projected recovery Quarter
4.3.8. Recovery Scenario – Short term, Midterm and Long Term Impact
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
5. Key Success Factors
5.1. Product USPs/ Features
5.2. Product Adoption / Usage Analysis
5.3. Epidemiology Scenario
5.4. Reimbursement Scenario
5.5. Regulatory Landscape
6. Global Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Opportunity Analysis, 2020-2030
7. Global Disposable Blood Bags Replacement Market – Pricing Analysis
7.1. Regional Pricing Analysis By Collection Bags
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
8. Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2020-2030
8.3.1. Proton Pump Inhibitors
8.3.2. Potassium-Competitive Acid Blocker (P-CAB)
8.3.3. Antacids
8.3.4. H2- Antagonists
8.3.5. Antibiotics
8.3.6. Ulcer Protective
8.4. Market Attractiveness Analysis By Product
9. Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030, By Indication
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015-2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020-2030
9.3.1. Gastritis
9.3.2. Gastric Ulcer
9.3.3. Duodenal Ulcer
9.3.4. Gastroesophageal Reflux Disease (GERD)
9.4. Market Attractiveness Analysis By Indication
10. Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030
10.3.1. Hospital Pharmacies
10.3.2. Private Clinics
10.3.3. Drug Stores
10.3.4. Retail Pharmacies
10.3.5. E-Commerce
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030, by Region
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Indication
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Latin America Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Europe Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. South Asia Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Indication
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. East Asia Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Indication
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Oceania Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Indication
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Indication
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Key and Emerging Countries Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Peptic Ulcer Drugs Market Analysis
19.2.1. By Product
19.2.2. By Indication
19.2.3. By Distribution Channel
19.3. Canada Peptic Ulcer Drugs Market Analysis
19.3.1. By Product
19.3.2. By Indication
19.3.3. By Distribution Channel
19.4. Mexico Peptic Ulcer Drugs Market Analysis
19.4.1. By Product
19.4.2. By Indication
19.4.3. By Distribution Channel
19.5. Brazil Peptic Ulcer Drugs Market Analysis
19.5.1. By Product
19.5.2. By Indication
19.5.3. By Distribution Channel
19.6. U.K. Peptic Ulcer Drugs Market Analysis
19.6.1. By Product
19.6.2. By Indication
19.6.3. By Distribution Channel
19.7. Germany Peptic Ulcer Drugs Market Analysis
19.7.1. By Product
19.7.2. By Indication
19.7.3. By Distribution Channel
19.8. France Peptic Ulcer Drugs Market Analysis
19.8.1. By Product
19.8.2. By Indication
19.8.3. By Distribution Channel
19.9. Italy Peptic Ulcer Drugs Market Analysis
19.9.1. By Product
19.9.2. By Indication
19.9.3. By Distribution Channel
19.10. Spain Peptic Ulcer Drugs Market Analysis
19.10.1. By Product
19.10.2. By Indication
19.10.3. By Distribution Channel
19.11. BENELUX Peptic Ulcer Drugs Market Analysis
19.11.1. By Product
19.11.2. By Indication
19.11.3. By Distribution Channel
19.12. Russia Peptic Ulcer Drugs Market Analysis
19.12.1. By Product
19.12.2. By Indication
19.12.3. By Distribution Channel
19.13. China Peptic Ulcer Drugs Market Analysis
19.13.1. By Product
19.13.2. By Indication
19.13.3. By Distribution Channel
19.14. Japan Peptic Ulcer Drugs Market Analysis
19.14.1. By Product
19.14.2. By Indication
19.14.3. By Distribution Channel
19.15. South Korea Peptic Ulcer Drugs Market Analysis
19.15.1. By Product
19.15.2. By Indication
19.15.3. By Distribution Channel
19.16. India Peptic Ulcer Drugs Market Analysis
19.16.1. By Product
19.16.2. By Indication
19.16.3. By Distribution Channel
19.17. ASEAN Peptic Ulcer Drugs Market Analysis
19.17.1. By Product
19.17.2. By Indication
19.17.3. By Distribution Channel
19.18. Australia Peptic Ulcer Drugs Market Analysis
19.18.1. By Product
19.18.2. By Indication
19.18.3. By Distribution Channel
19.19. New Zealand Peptic Ulcer Drugs Market Analysis
19.19.1. By Product
19.19.2. By Indication
19.19.3. By Distribution Channel
19.20. GCC Countries Peptic Ulcer Drugs Market Analysis
19.20.1. By Product
19.20.2. By Indication
19.20.3. By Distribution Channel
19.21. Turkey Peptic Ulcer Drugs Market Analysis
19.21.1. By Product
19.21.2. By Indication
19.21.3. By Distribution Channel
19.22. South Africa Peptic Ulcer Drugs Market Analysis
19.22.1. By Product
19.22.2. By Indication
19.22.3. By Distribution Channel
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. Regional Footprint by Players
20.3.2. Product Foot print by Players
20.3.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive (Tentative List)
21.3.1. Pfizer Inc.
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Analyst commentary
21.3.2. Abbvie Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Analyst commentary
21.3.3. GlaxoSmithKline plc.
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Analyst commentary
21.3.4. AstraZeneca plc
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Analyst commentary
21.3.5. Boehringer Ingelheim GmbH
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Analyst commentary
21.3.6. Daewoong Pharmaceutical Co., Ltd.
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Analyst commentary
21.3.7. Takeda Pharmaceutical
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Analyst commentary
21.3.8. Eisai Co. Ltd.
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Analyst commentary
21.3.9. Cadila Healthcare Ltd.
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Analyst commentary
21.3.10. Yuhan Corporation
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Analyst commentary
22. Assumptions and Acronyms Used
23. Research Methodology
List of Tables:Table 01: Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 02: Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 03: Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
Table 04: Global Peptic Ulcer Drugs Market Analysis 2015-2019 and Forecast 2020–2030, By Region
Table 05: North America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 06: North America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 07: North America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 08: North America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
Table 09: Latin America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 10: Latin America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 11: Latin America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 12: Latin America Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
Table 13: Europe Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 14: Europe Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 15: Europe Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 16: Europe Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
Table 17: South Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 18: South Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 19: South Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 20: South Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
Table 21: East Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 22: East Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 23: East Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 24: East Asia Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel
Table 25: Oceania Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 26: Oceania Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 27: Middle East and Africa Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 28: Middle East and Africa Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Product
Table 29: Middle East and Africa Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Indication
Table 30: Middle East and Africa Peptic Ulcer Drugs Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel